2018
DOI: 10.1016/j.jmig.2018.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Factors Associated with Malignancy in Hysteroscopically Resected Endometrial Polyps: A Systematic Review and Meta-Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
32
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 58 publications
(44 citation statements)
references
References 48 publications
3
32
0
1
Order By: Relevance
“…The frequency of premalignant and malignant lesions in endometrial polyps was reported to be 3.4%, and there was high heterogeneity among the studies (I, 80.5%; P<0.05) [12]. Kilicdag et al [13] reported the prevalence of premalignancy or malignancy as 2.2% (0.5% hyperplasia with atypia and 1.7% endometrial adenocarcinoma) among the large sample size of premenopausal women (417 patients) with endometrial polyps.…”
Section: Discussionmentioning
confidence: 99%
“…The frequency of premalignant and malignant lesions in endometrial polyps was reported to be 3.4%, and there was high heterogeneity among the studies (I, 80.5%; P<0.05) [12]. Kilicdag et al [13] reported the prevalence of premalignancy or malignancy as 2.2% (0.5% hyperplasia with atypia and 1.7% endometrial adenocarcinoma) among the large sample size of premenopausal women (417 patients) with endometrial polyps.…”
Section: Discussionmentioning
confidence: 99%
“…Außerdem können Endometriumkarzinome vom Typ II innerhalb von glandulär-zystischen Korpuspolypen entstehen [33]. Eine aktuelle Metaanalyse zeigt eine Prävalenz prämaligner und maligner Läsionen in Endometriumpolypen von 3,4 % (95 %-Konfidenzintervall, 2,8-4,1) [34]. Daher sollten eine diagnostische Hysteroskopie sowie fraktionierte Abrasio und Polypabtragung zur weiteren Abklärung durchgeführt werden.…”
Section: Therapieunclassified
“…Further, cross-validation showed that no study exerted a big influence on the pooled prevalence estimate. Nonetheless, we were unable to identify and quantify the relevant epidemiological and clinical parameters that may predict hyperplasia and cancer in endometrial polyps, such as recurrent PMB, body mass index (BMI), hypertension, diabetes, and endometrial thickness 5,7,12 because of inconsistent or lack of reporting in various studies. This precluded further subgroup analyses and meta-regression.…”
Section: Strengths and Limitationsmentioning
confidence: 99%
“…7,11,12 This makes it difficult to produce guidelines for management. Further, one randomised controlled trial (RCT) 13 and three systematic reviews 7,11,12 failed to produce evidence as regards the best management of endometrial polyps in women with PMB. The RCT was discontinued after 26 months because of lack of recruitment to the expectant management arm.…”
Section: Introductionmentioning
confidence: 99%